We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.23B
AUM Growth
+$59.4M
Cap. Flow
+$16.2M
Cap. Flow %
1.31%
Top 10 Hldgs %
42.86%
Holding
211
New
11
Increased
78
Reduced
63
Closed
10

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$3.22M
2
PNC icon
PNC Financial Services
PNC
+$2.38M
3
NEE icon
NextEra Energy
NEE
+$2.23M
4
VZ icon
Verizon
VZ
+$1.82M
5
STJ
St Jude Medical
STJ
+$1.53M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.24%
2 Healthcare 14.87%
3 Financials 10.21%
4 Technology 9.69%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPP icon
201
WPP
WPP
$4.04B
-5,686
Closed -$662K
CAA
202
DELISTED
CalAtlantic Group, Inc.
CAA
-11,106
Closed -$371K
STJ
203
DELISTED
St Jude Medical
STJ
-27,760
Closed -$1.53M
BXLT
204
DELISTED
BAXALTA INC COM STK (DE)
BXLT
-20,095
Closed -$812K
SNDK
205
DELISTED
SANDISK CORP
SNDK
-17,100
Closed -$1.3M
HOT
206
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
-16,800
Closed -$1.4M

Similar funds

Cullinan Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Cullinan Associates held 211 positions worth $1.23B, up 5.1% from $1.17B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q2 2016 filing shows 11 new, 78 increased, 63 reduced and 10 closed positions. Its largest new stake was Charles Schwab: 104,400 shares worth $2.64M. The largest sale was Aflac, an estimated $3.22M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q2 2016 buy was Charles Schwab: 104,400 shares worth $2.64M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q2 2016, an estimated $6.27M increase.
  • Cullinan Associates's biggest Q2 2016 reduction was Aflac, cutting an estimated $3.22M.
  • Cullinan Associates fully exited St Jude Medical in Q2 2016, selling an estimated $1.53M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.23B portfolio in Q2 2016.
  • Cullinan Associates opened 11 new positions and closed 10 in Q2 2016.
  • Cullinan Associates's portfolio value rose 5.1% quarter-over-quarter to $1.23B.

Based on Cullinan Associates's 13F filing for Q2 2016, filed 1 Jul 2016.